| KOTAK MIDCAP FUND
Mid Cap Fund - An open ended equity scheme predominantly investing in mid cap stocks
Mid Cap Fund - An open ended equity scheme predominantly investing in mid cap stocks
| KOTAK MIDCAP FUND
Mid Cap Fund - An open ended equity scheme predominantly investing in mid cap stocks
(as on July 31, 2026)
Source: $ICRA MFI Explorer, ^^Bloomberg
***As per para 7.2 of SEBI Master circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.41% (FBIL Overnight MIBOR rate as on 31st July 2026).**The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'
Mid Cap Fund - An open ended equity scheme predominantly investing in mid cap stocks
 |
 |
  
|
|
|
|
Investment Objective
The investment objective of the scheme is to generate long-term capital appreciation from a portfolio of equity and
equity related securities, by investing predominantly in mid companies. The scheme may also invest in Debt and Money Market Instruments, as
per the asset allocation table. However, there is no assurance that the objective of the scheme will be achieved.
The investment objective of the scheme is to generate long-term capital appreciation from a portfolio of equity and
equity related securities, by investing predominantly in mid companies. The scheme may also invest in Debt and Money Market Instruments, as
per the asset allocation table. However, there is no assurance that the objective of the scheme will be achieved.
| Issuer/Instrument | |
% to Net Assets |
|---|---|---|
| Equity & Equity related | ||
| Finance | 12.20 | |
| L&T FINANCE LTD | 2.85 | |
| Cholamandalam Investment and Finance Company Ltd. | 1.80 | |
| HDB FINANCIAL SERVICES LTD | 1.55 | |
| POONAWALLA FINCORP LTD. | 1.32 | |
| PIRAMAL FINANCE LTD | 1.18 | |
| REC LTD | 1.17 | |
| Power Finance Corporation Ltd. | 0.90 | |
| INDIA SHELTER FINANCE CORPORATION LTD | 0.77 | |
| HOME FIRST FINANCE CO INDIA | 0.66 | |
| Retailing | 9.16 | |
| ETERNAL LIMITED | 3.24 | |
| VISHAL MEGA MART LIMITED | 3.06 | |
| SWIGGY LTD | 1.61 | |
| LENSKART SOLUTIONS LIMITED | 1.25 | |
| Healthcare Services | 8.32 | |
| Fortis Healthcare India Ltd | 3.83 | |
| Global Health Ltd. | 1.80 | |
| ASTER DM HEALTHCARE LTD | 1.10 | |
| MAX HEALTHCARE INSTITUTE LTD. | 0.85 | |
| Apollo Hospitals Enterprises Ltd. | 0.58 | |
| MANIPAL HEALTH ENTERPRISES LTD | 0.16 | |
| Banks | 7.64 | |
| FEDERAL BANK LTD. | 2.85 | |
| INDIAN BANK | 2.24 | |
| BANK OF MAHARASHTRA | 2.08 | |
| City Union Bank Ltd. | 0.47 | |
| Pharmaceuticals and Biotechnology | 7.30 | |
| Ipca Laboratories Ltd. | 3.12 | |
| TORRENT PHARMACEUTICALS LTD. | 1.38 | |
| EMCURE PHARMACEUTICALS LIMITED | 1.02 | |
| Biocon Ltd. | 0.97 | |
| RUBICON RESEARCH LTD | 0.81 | |
| Auto Components | 6.71 | |
| Schaeffler India Ltd | 2.14 | |
| BHARAT FORGE LTD. | 1.34 | |
| MRF Limited | 0.94 | |
| UNO MINDA LIMITED | 0.85 | |
| ZF Commercial Vehicle Control Systems India Limited | 0.75 | |
| Apollo Tyres Ltd. | 0.69 | |
| IT - Software | 6.62 | |
| Mphasis Ltd | 2.68 | |
| PERSISTENT SYSTEMS LIMITED | 1.62 | |
| ORACLE FINANCIAL SERVICES SOFTWARE LTD | 1.51 | |
| Birlasoft Ltd. | 0.81 | |
| Consumer Durables | 5.53 | |
| DIXON TECHNOLOGIES INDIA LTD. | 2.03 | |
| BLUE STAR LTD. | 1.28 | |
| Metro Brands Ltd. | 1.22 | |
| VOLTAS LTD. | 1.00 | |
| Capital Markets | 4.84 | |
| NUVAMA WEALTH MANAGEMENT LIMITED | 1.68 | |
| NIPPON LIFE INDIA ASSET MANAGEMENT LTD. | 1.59 | |
| Prudent Corporate Advisory Services Ltd. | 0.91 | |
| BSE LTD. | 0.66 | |
| Chemicals and Petrochemicals | 4.68 | |
| SOLAR INDUSTRIES INDIA LIMITED | 2.16 | |
| SRF Ltd. | 1.54 | |
| Deepak Nitrite Ltd. | 0.98 | |
| Electrical Equipment | 4.33 | |
| GE VERNOVA T&D INDIA LIMITED | 2.42 | |
| Apar Industries Limited | 1.91 | |
| Industrial Products | 3.12 | |
| KEI INDUSTRIES LTD. | 2.47 | |
| Ratnamani Metals & Tubes Ltd. | 0.65 | |
| Fertilizers and Agrochemicals | 2.95 | |
| Coromandel International Ltd. | 1.71 | |
| P I INDUSTRIES LTD | 1.24 | |
| Cement and Cement Products | 2.33 | |
| Dalmia Bharat Limited | 1.21 | |
| JK Cement Ltd. | 1.12 | |
| Insurance | 2.24 | |
| Max Financial Services Ltd. | 1.24 | |
| ICICI LOMBARD GENERAL INSURANCE COMPANY LTD | 1.00 | |
| Telecom - Services | 2.17 | |
| BHARTI HEXACOM LTD. | 2.17 | |
| Realty | 2.09 | |
| OBEROI REALTY LTD | 2.09 | |
| Aerospace and Defense | 1.88 | |
| Bharat Electronics Ltd. | 1.88 | |
| Petroleum Products | 1.30 | |
| HINDUSTAN PETROLEUM CORPORATION LTD | 1.30 | |
| Food Products | 0.94 | |
| AVANTI FEEDS LTD | 0.94 | |
| Ferrous Metals | 0.83 | |
| Jindal Steel & Power Ltd. | 0.83 | |
| Beverages | 0.39 | |
| UNITED SPIRITS LTD. | 0.39 | |
| Construction | 0.36 | |
| TECHNO ELECTRIC & ENGINEERING COMPANY LIMITED | 0.36 | |
| Equity & Equity Related - Total | 97.93 | |
| Mutual Fund Units | ||
| Kotak Liquid Direct Growth | 0.17 | |
| Mutual Fund Units - Total | 0.17 | |
| Futures | ||
| DIXON TECHNOLOGIES INDIA LTD.-AUG2026 | 0.36 | |
| KEI INDUSTRIES LTD.-AUG2026 | 0.17 | |
| SWIGGY LTD-AUG2026 | 0.09 | |
| OBEROI REALTY LTD-AUG2026 | 0.01 | |
| Triparty Repo | 1.22 | |
| Net Current Assets/(Liabilities) | 0.68 | |
| Grand Total | 100.00 | |
| Monthly SIP of (₹) 10000 | Since Inception | 10 years | 7 years | 5 years | 3 years | 1 year |
| Total amount invested (₹) | 23,30,000 | 12,00,000 | 8,40,000 | 6,00,000 | 3,60,000 | 1,20,000 |
| Total Value as on July 31, 2026 (₹) | 1,70,68,268 | 32,00,499 | 17,54,367 | 9,17,200 | 4,40,503 | 1,28,983 |
| Scheme Returns (%) | 17.82 | 18.65 | 20.68 | 17.01 | 13.58 | 14.23 |
| Nifty Midcap 150 (TRI) Returns (%) | 17.53 | 19.14 | 21.63 | 17.53 | 12.17 | 13.78 |
| Alpha* | 0.29 | -0.49 | -0.95 | -0.52 | 1.40 | 0.45 |
| Nifty Midcap 150 (TRI) (₹)# | 1,64,84,449 | 32,85,594 | 18,14,490 | 9,28,862 | 4,31,671 | 1,28,702 |
| Nifty Midcap 100 (TRI) Returns (%) | 16.51 | 18.82 | 22.19 | 18.20 | 12.66 | 14.48 |
| Alpha* | 1.31 | -0.17 | -1.51 | -1.19 | 0.92 | -0.24 |
| Nifty Midcap 100 (TRI) (₹)# | 1,45,73,595 | 32,29,550 | 18,50,648 | 9,44,188 | 4,34,705 | 1,29,133 |
| Nifty 50 (TRI) (₹)^ | 83,97,338 | 22,36,435 | 12,67,639 | 7,36,949 | 3,84,937 | 1,19,609 |
| Nifty 50 (TRI) Returns (%) | 11.85 | 11.97 | 11.56 | 8.16 | 4.41 | -0.61 |
Scheme Inception : - March 30, 2007. The returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated
accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein are of Regular Plan - Growth
Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of Para no 7.23 of SEBI Master Circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026, the performance of the
scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing
NAV. Source: ICRA MFI Explorer.
Net Asset Value (NAV)
| Regular | Direct | |
| Growth | Rs145.9250 | Rs170.6770 |
| IDCW | Rs80.1460 | Rs101.6870 |
Available Plans/Options
A) Regular Plan B) Direct Plan
Options: Payout of IDCW, Reinvestment of
IDCW & Growth (applicable for all plans)
| Fund Manager* |
Mr. Atul Bhole |
| Benchmark*** | NIFTY Midcap 150 TRI (Tier 1), Nifty Midcap 100 TRI (Tier 2) |
| Allotment date | March 30, 2007 |
| AAUM | Rs68,869.69 crs |
| AUM | Rs69,282.83 crs |
| Folio count | 21,69,892 |
IDCW Frequency
Trustee's Discretion
Ratios
| Portfolio Turnover | 26.70% |
| $Beta | 0.93 |
| $Sharpe ## | 0.75 |
| $Standard Deviation | 17.79% |
| ^^(P/E) | 30.66 |
| ^^P/BV | 4.50 |
Market Capitalisation*
| Large Cap | 15.67% |
| Mid Cap | 68.21% |
| Small Cap | 14.68% |
| Debt & Money Market | 1.44% |
*% of Net Asset
Minimum Investment Amount
Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter
Ideal Investments Horizon
• 5 years & above
Load Structure
Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out of upto 10%
of the initial investment amount (limit)
purchased or switched in within 1 year from
the date of allotment: Nil.
• If units redeemed or switched out are in
excess of the limit within 1 year from the
date of allotment: 1%
• If units are redeemed or switched out on
or after 1 year from the date of allotment:
NIL.
Expense Ratio**
| Regular Plan: | 1.37% |
| Direct Plan: | 0.39% |
Data as on 31st July, 2026 unless
otherwise specified.
Folio Count data as on 30th July 2026.
Folio Count data as on 30th July 2026.
Fund
Benchmark - Tier 1: Nifty Midcap 150 TRI
Benchmark - Tier 2: Nifty Midcap 100 TRI
This product is suitable for investors who are seeking*:
Benchmark - Tier 1: Nifty Midcap 150 TRI
Benchmark - Tier 2: Nifty Midcap 100 TRI
This product is suitable for investors who are seeking*:
- Long term capital growth
- Investment in equity & equity related securities predominantly in mid cap companies.
* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.
For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com
***As per para 7.2 of SEBI Master circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.41% (FBIL Overnight MIBOR rate as on 31st July 2026).**The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'